Improving melanoma diagnostic tools
Source: Medical Xpress, August 2022
New QIMR Berghofer research has identified a dramatic increase in the treatment of “pre-cancerous" melanomas in Australia and found strong evidence that similar trends are emerging across the globe.
The study suggests that many of these pre-cancers may not actually be harmful to the patient and, therefore, may not have needed treatment.
In an attempt to understand why melanoma incidence has been rising around the world, lead researcher, Professor David Whiteman, and colleagues examined long-term skin cancer trends in Queensland, Scotland and the United States, using a new statistical method developed by co-authors at the U.S. National Cancer Institute, part of the U.S. National Institutes of Health.